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DumpingAnalysis of wastewater with an aim of community-wide estimation of drug use is a new and very promising
approach. Until now it was very difﬁcult to determine if mass loads of studied drugs were actually originating
from consumption, or disposal of unused drugs or production waste. This uncertainty in the estimation of commu-
nitywide drugs use should not be underestimated. This paper aims to apply for theﬁrst time enantiomeric proﬁling
in verifying sources of the presence ofMDMA and amphetamine inwastewater based on a case study in twoDutch
cities: Utrecht and Eindhoven. The results showed thatMDMA is usually present inwastewater due to its consump-
tion (MDMA enrichedwith R(−)-enantiomer). Excessively highmass loads ofMDMAduring a sampling campaign
in Utrecht in 2011 proved to be racemic indicating direct disposal of unused MDMA possibly as a result of a police
raid at a nearby illegal production facility. Enantiomeric proﬁlingwas also undertaken in order to verify the origin of
unexpectedly high mass loads of amphetamine in the city of Eindhoven in 2011. Unfortunately, a distinction
between consumption and direct disposal of unused amphetamine in Dutch wastewater could not be achieved.
Further work will have to be undertaken to fully understand sources of amphetamine in Dutch wastewaters.
Crown Copyright © 2013 Published by Elsevier B.V. Open access under CC BY license.r B.V. Open access under CC BY license1. Introduction
Analysis of wastewater with an aim of community wide estimation
of drug use is a new and very promising approach. It was ﬁrst proposed
by Daughton in 2001 (Daughton, 2001), implemented by Zuccato et al. in.
667E. Emke et al. / Science of the Total Environment 487 (2014) 666–6722004 (Zuccato et al., 2005) and followed by others (Banta-Green et al.,
2009; Bones et al., 2007; Castiglioni et al., 2011; Harman et al., 2011;
Huerta-Fontela et al., 2008; Karolak et al., 2010; Kasprzyk-Hordern
et al., 2009; Mari et al., 2009; Metcalfe et al., 2010; Postigo et al., 2010;
Terzic et al., 2010; Van Nuijs et al., 2009; de Voogt et al., 2011d). Those
wanting to ﬁnd out more about this new concept are referred to existing
reviews (Postigo et al., 2008; Van Nuijs et al., 2010; Zuccato et al., 2008).
In 2009 for the ﬁrst time the watercycle of The Netherlands was investi-
gated (Van der Aa et al., 2013) followed by another campaign in 2010
(Bijlsma et al., 2012).
The ﬁrst joint European initiative including 19 European cities
took place in 2011 (Thomas et al., 2012). It attempted to harmonise
the sampling protocol, estimate uncertainties of the approach
(Castiglioni et al., 2013) and to compare drug loads to sewage treatment
plants in 19 European cities (Thomas et al., 2012). For several types of
drugs, e.g. phenethylamines, until now itwas very difﬁcult to determine
if loads were actually originating from consumption, or disposal of un-
used drugs or production waste. This uncertainty in the estimation of
community wide drugs use should not be underestimated.
The Netherlands and Belgium are known for producing high amounts
of MDMA (European Monitoring Centre for Drugs and Drug Addiction,
2010) and their contribution to theworldmarket, based on seizures is es-
timated at 38.5% according to theUNODC (UnitedNationsOfﬁce onDrugs
and Crime, 2009). Remarkably, despite increased seizures in 2010 no
MDMA laboratories were reported to the UNODC being seized in The
Netherlands and Belgium. However, in 2011 several laboratories were
seized (United Nations Ofﬁce on Drugs and Crime, 2012). The chemical
waste which is generated from illegally produced MDMA also needs to
be disposed. The most common way to dispose of it is through direct
dumping in the environment. These incidents have dramatically in-
creased in recent years. In 2011 there were 60 recorded incidences of di-
rect disposal to the environment, which rose to 90 in 2012 and further
increased in 2013 (reached 90 by mid-2013) (Klaren, 2013). In 37.5% of
the incidents, one or more of the disposed containers were leaking or
they were set to ﬁre (Sanoma Digital, The Netherlands B.V., 2013).
Otherways of disposing of chemicalwaste generated from illegal produc-
tion of MDMA in The Netherlands include disposal while driving a ma-
nure tank or direct disposal to rivers or sewers. Due to the shortage of
the precursor PMK, production has been shifting to alternative synthesis
routes resulting in an additional step in the synthesis and creating also
more chemical waste.
When analysis of wastewater for the presence of illegal drugs in a
studied community is done regularly using frequent sampling intervals
a sort of base line of daily drug loads can be estimated. In some cases,
however, aberrantly high loads could be observedwhich are not in con-
junction with the actual drugs consumed in that speciﬁc community.
These abnormally high loads might result from examples of direct
disposal of unused drugs and/or production waste mentioned above,
making the epidemiological estimation of community-wide drug use
via wastewater analysis difﬁcult and unreliable. It is therefore of the
utmost importance to introduce new approaches allowing for making
a distinction between consumption and direct disposal of unused
drugs to wastewater.
Enantiomeric proﬁling of drugs in wastewater could be a viable
option to solving above mentioned problems (Kasprzyk-Hordern and
Baker, 2012b). Many of the popular psychoactive drugs (e.g., cocaine,
amphetamines, cathinones) contain one or more asymmetric carbon
atoms. Chemical synthesis of compounds containing one asymmetric
C atom will generally lead to equal amounts of the two corresponding
enantiomers in the product synthesised. Metabolism of a product
containing a racemic mixture of the enantiomers will change the enan-
tiomeric ratio as a result of differences in metabolic conversion rates of
the enantiomers. The main aim of this paper is to apply enantiomeric
proﬁling in qualifying sources of the presence of MDMA and amphet-
amine in wastewater based on a case study in two Dutch cities: Utrecht
and Eindhoven.2. Experimental
2.1. Chemicals and materials
Reference standards: R/S(±)-amphetamine and R/S(±)-3,4-
methylene-dioxymethamphetamine (MDMA), were purchased from
Lipomed AG (Arlesheim, Switzerland) as solutions in methanol (MeOH)
at a concentration of 1 g/L. Internal standards (IS): R/S(±)-amphet-
amine-d11 and R/S(±)-MDMA-d5 were purchased from Lipomed AG
The internal standards were added prior to the sample treatment.
2.2. Sampling and sample treatment
Two one-week monitoring programmes were undertaken in
2010 and 2011. In 2010, inﬂuents from ﬁve Dutch sewage treatment
plants (STPs) were collected in weeks 7–8 from the cities of
Amsterdam, Utrecht Eindhoven, Apeldoorn and the Schiphol airport
(Bijlsma et al., 2012). In 2011, inﬂuents from the same STPs in the cities
of Amsterdam, Utrecht and Eindhoven were collected in weeks 10–11
as part of a study to compare loads of drugs of abuse in 19 European cit-
ies (Thomas et al., 2012). From these two campaignswewill take a clos-
er look at two STPs. The ﬁrst is the STP of the city of Utrecht which has a
catchment area covering only the city and the maximum distance to
the STP is 8 km. The efﬂuent of this STP is partly recirculated into the
inﬂuent. The second STP is that of the city of Eindhoven which has a
catchment area covering the city but also neighbouring villages and
has amaximumdistance to the STP of 27 km (see Fig. 1). Both sampling
weeks happened to be immediately after the Carnival week of the
corresponding year.
All samples were taken in high density polyethylene sample bottles
by volume proportional sampling during a twenty four hour cycle. The
sampling equipment was setup to take a discrete sample of 50 mL
every 400 m3 for Utrecht and every 800 m3 for Eindhoven. In this way
the average sampling frequency was for Utrecht 5.5 min in 2010 and
6.8 min in 2011 and for Eindhoven every 8.2 min in 2010 and every
7.2 min in 2011 which are all well below the considered minimal sam-
pling frequency for ﬂow proportional sampling of 15 min (Ort et al.,
2010). For each city samples were collected on 7 consecutive days
accordingly. After collection of the samples they were immediately
stored at −18 °C. Before extraction the samples were transferred to
storage at 4 °C to allow the frozen sample to be defrosted. The samples
were then adjusted to pH 7 and amixed solution of deuterated internal
standards was added. The samples were then ﬁltered through a 1.0 μm
glass ﬁbre ﬁlter and followed by a 0.2 μm ﬁlter (polyethersulfon). A
100 mL aliquot of the ﬁltered sample was extracted using Solid Phase
Extraction (SPE) cartridges (150 mg Oasis HLB) via an automated ex-
traction and elution setup (GX-274 ASPEC, Gilson Middleton, USA)
The methanol eluates were then further automatically concentrated
(Barkey, Optocontrol, Germany) by using heated nitrogen and made
up to reach a ﬁnal extract of 90/10 water and methanol.
2.3. Analysis
Twomethodologies were used to identify and quantify chiral drugs in
wastewater. Identiﬁcation and quantiﬁcation of drugs was undertaken
with non-chiral HPLC–LTQ–Orbitrap–MS method. SPE-chiral–LC–MS/
MSwas used for the veriﬁcation of enantiomeric fractions of chiral drugs.
2.3.1. Identiﬁcation and quantiﬁcation of chiral drugs with HPLC–LTQ–
Orbitrap–MS
A hybrid LTQ–Orbitrap mass spectrometer (Thermo Electron, Bre-
men, Germany) provided with an electro spray ionisation source was
interfaced to a Surveyor HPLC system (Thermo Electron). For the chro-
matographic separation an XBridge C18 column (150 mm × 2.1 mm
I.D., particle size 3.5 μm) (Waters, Etten-Leur, The Netherlands) preced-
ed by a 4.0 mm × 2.0 mm I.D. Phenomenex Security Guard column
Fig. 1. Sampling locations with their respective catchment area.
Table 1
Acquisition and validation parameters for SPE–HPLC–LTQ–Orbitrap–MSmethod.
Compound Amphetamine MDMA
Precursor ion [M + H]+ m/z 136.11208 194.11755
Normalised collision energy 35 35
Production 1 m/z 119.1 163.1
Production 2 m/z 91.1 58
Abundance % 0.5 1
RSD abundancea % 15 21.3
Internal standard Amphetamine-d11 MDMA-d5
Inﬂuent LOQb ng L−1 40 12
Linearityc r2 0.9960 0.9999
Instrumental LOQb pg 58 14
a de Voogt et al. (2011).
b Bijlsma et al. (2013).
c Linearity range studied: 0.7–288 μg/L.
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was used. From the extract 20 μL was injected, and by using a gradient
of ultra-pure water (Milli Q, Millipore, Billerica, USA) and methanol
both with 0.05% formic acid, the compounds were separated at a
constant ﬂow of 0.3 mL/min and directly introduced to the mass spec-
trometer. With every batch run mass calibration was performed by
using a mix of polytyrosine 1,3,6 solution at a ﬂow rate of 10 μL/min.
The capillary used was a metal needle maintained at a temperature of
300 °C. For the ionisation nitrogen gas was used, the sheath, auxiliary
and sweep gas was set to arbitrary units of 30, 10 and 10. A source
voltage of 3.6 kV and a capillary voltage of 35 V were used only in the
positive mode. The tube lens was set to 50 V. Full scan high accuracy
mass spectra acquired in the range of 150–400 m/z with the resolution
set at 30,000 were used for quantiﬁcation with a 5 ppm mass window.
For conﬁrmation a list of target compounds was speciﬁed and when
a preset threshold of 10,000 counts was exceeded the LTQ iontrap
triggered to product-ion scan mode and hence conﬁrming the identity.
The acquisition and validation parameters for this method can be found
in Table 1. More details on the analytical procedure are provided in
(Bijlsma et al., 2012; Bijlsma et al., 2013).2.3.2. Enantiomeric separation of chiral drugs with chiral LC–MS/MS
A Waters ACQUITY UPLC™ system (Waters, Manchester, UK)
consisting of a ACQUITY UPLC™ binary solvent manager and a
Table 2
Optimised MRM conditions for the analysis of chiral drugs by UPLC/MS/MS (CV — cone
voltage [V]; CE— collision energy [eV]).
Analyte CV/CE MRM1
(quantiﬁcation)
CV/CE MRM2
(conﬁrmation)
R/S(±)-Amphetamine 18/8 136.16 N 119.10 18/16 136.16 N 91.10
R/S(±)-MDMA 24/13 194.09 N 163.10 24/24 194.09 N 105.10
R/S(±)-Amphetamine-d11 18/8 147.16 N 130.10 – –
R/S(±)-MDMA-d5 26/13 199.1 N 165.10 – –
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Fig. 2. Daily mass loads of MDMA of wastewater entering the STP in Utrecht calculated
from samples collected during a week in years 2010 and 2011, respectively.
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A Chiral-CBH column, 100 × 2 mm, 5 μm (Chromtech, Congleton, UK)
and a Chiral-CBH 10 × 2.0 mm guard column (Chromtech) were used
for the separation of enantiomers of amphetamine, MDA and MDMA.
The separation of chiral drugs was undertaken under isocratic conditions
with the usage of mobile phase composed of 90% H2O, 10% 2-propanol
and 1 mM ammonium acetate. 20 μL of the sample was injected into
the system. The column was kept at 25 °C and the temperature in the
sample manager was kept at 4 °C. The ﬂow rate of mobile phase was
0.075 mL/min, which allowed for the introduction of mobile phase from
LC into MS without splitting.
A Xevo TQD (triple quadrupole) mass spectrometer (Waters,
Manchester, UK), equipped with an electrospray ionisation source,
was used for the quantiﬁcation of the chiral drugs. The analyses were
performed in positivemodewith a capillary voltage of 3.13 kV, a source
temperature of 150 °C and a desolvation temperature of 150 °C. A cone
gas ﬂow of 50 L/h and desolvation gas ﬂow of 650 L/h were used. Nitro-
gen, used as a nebulising and desolvation gas, was provided by a high
purity nitrogen generator (Peak Scientiﬁc Instruments Ltd, UK). Argon
(99.999%) was used as a collision gas. MassLynx 4.1 (Waters, UK) soft-
warewas used to collect and analyse the obtained data. Mass spectrom-
etry analyses were performed in the multiple reaction monitoring
(MRM) mode, measuring the fragmentation of the protonated
pseudo-molecular ions of each chiral drug (Table 2). Validation param-
eters for this method can be found in Table 3.
The relative concentration of enantiomers of chiral drugs
was expressed as the enantiomeric fraction (EF) and was calculated
with the following equation:
EF ¼ R −ð ÞA=R −ð ÞIS
R −ð ÞA=R −ð ÞIS þ S þð ÞA=S þð ÞIS
where R(−)A and S(+)A are the peak areas for R(−) and S(+) enantio-
mers of a chiral drug; R(−)IS and S(+)IS are peak areas for R(−) and
S(+) enantiomers of corresponding internal standards.
EF equals 1 or 0 in the case of single enantiomer form and 0.5 in the
case of racemate.
Resolution of enantiomers of chiral drugs (Rs) was calculated using
the following equation:
ERs ¼
2 trE2−trE1ð Þ
wbE2 þwbE1Table 3
Validation parameters for SPE-Chiral LC–MS/MS method.
Analyte Instrumental parameters
EFo ± SD⁎ ERs ± SD
Amphetamine R(−) 0.51 ± 0.02 1.92 ± 0
(IS: AMPH-d11) S(+)
MDMA R(−) 0.48 ± 0.01 1.99 ± 0
(IS: MDMA-d5) S(+)
IS— Internal standard.
⁎ EFo — enantiomeric fraction in standard solution spiked with racemic chiral drug (concen
⁎⁎ ERs — Enantiomeric resolution.
⁎⁎⁎ Studied linearity range: IDL-144 μg/L.where: trE1, trE2 are the retention times of the ﬁrst- and second-eluted
enantiomers and wbE1, wbE2 are the widths of these responses at the
base line.
Formore details on analytical procedure please refer to the following
publications: (Kasprzyk-Hordern and Baker, 2012a,b).3. Results and discussion
3.1. MDMA in the city of Utrecht
3.1.1. Loads of MDMA in sewage inﬂuents
The average weekly normalised load of MDMA in the inﬂuent from
the city of Utrecht in 2011 was 615 mg/day/1000 inhabitants (Thomas
et al., 2012) corresponding to an average daily load to the STP of
184 g/day. This loadwould roughly correspond to an average consump-
tion of 1.2 kg MDMA per day, taking into account an excretion factor of
6.7 (Abraham et al., 2009). Assuming a dose of 100 mg of pure MDMA
per person per day this load would correspond to a prevalence of 5.5%
for the people between 15 and 64 years living in Utrecht, which is 4
times higher than the last reported ﬁgure of 1.4% in 2009 (European
Monitoring Centre for Drugs and Drug Addiction, Statistical Bulletin,
2012). This average prevalence is highly unrealistic as it is twice the
ﬁgure of 2.4% of the United Kingdom. It is important to note that the
same STP in the city of Utrecht was also subject to monitoring for a
period of 7 days in 2010 (Bijlsma et al., 2012). The loads of MDMA to
the STP (in g/day) observed in both sampling campaigns are shown
in Fig. 2. The average weekly load of MDMA of 184 g/day in 2011 is 20
times higher than the average load observed in 2010 (9.3 g/day).
These results raised suspicions about the origin of the high MDMA
loads observed in 2011. After viewing police reports on the internet it
became clear that a possible cause for the abnormally high levels
could be connected to a police raid into a private home in Utrecht
2 days before the sampling started in 2011. The location raided ap-
peared to be equipped for producing MDMA tablets, but only starting
materials, additives, empty tablet bags and a few tablets were found.
The police estimated that the total amount in the empty bags could
have been a total of 30 kg comparable with more than half a million
of XTC tablets.⁎⁎ R2⁎⁎⁎ IDL (S/N N 3) IQL (S/N N 10)
.12 0.9996 0.3 1.4
0.9999 0.3 0.7
.16 0.9997 0.3 0.7
0.9998 0.3 0.7
trations: IDL-144 μg/L).
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water observed in 2011 result from consumption or direct disposal of un-
used MDMA, enantiomeric proﬁling of wastewater was undertaken.
3.1.2. Enantiomeric proﬁling of MDMA in wastewater
MDMA has one asymmetric carbon centre and therefore it can exist
in the form of two enantiomers, which differ both quantitatively and
qualitatively in pharmacological activity: S(+)-enantiomers are more
amphetamine-like stimulants and R(−)-enantiomers are more halluci-
nogenic (Fantegrossi, 2008). MDMA's enantiomers have different sero-
tonin (5-HT) neurotoxicity: S(+)-MDMA is a more potent neurotoxin
than R(−)-MDMA (Moore et al., 1996). There are four principal precur-
sors, which can be used in manufacture of MDMA and related drugs:
safrole, isosafrole, piperonal, 3,4-methylenedioxyphenyl-2-propanone
(Piperonylmethylketone, PMK). Many illicit syntheses start with PMK
and use either the Leuckart route or various reductive aminations
(Renton et al., 1993). All of these methods produce racemic MDMA
(King, 2009). S(+)-MDMA is however known to undergo preferential
metabolism over R(−)-MDMA, which leads to enrichment of MDMA
with R(−)-enantiomer and preferential formation of S(+)-MDA.
Moore et al. (1996) observed that both primary routes of excretion in
human (bile and urine) had greater concentrations of R(−)-MDMA
than the S(+) isomer (EF of 0.57, autopsy ﬁndings). These ﬂuids also
contained twice the concentration of S(+)-MDA than the R(−)-isomer
(EF = 0.37, autopsy ﬁndings) as reported by Moore et al. (1996). This
is very important information, which allows for the veriﬁcation of
whether drug residue present in wastewater results from its actual
consumption (EF N 0.5) or direct disposal (EF = 0.5). As MDMA does
not currently have medical applications its presence in biological speci-
men is believed to result from its abuse.
The results of the present study (Fig. 3) indicate that during 2010
sampling campaign, MDMA was found in wastewater in the form
enriched with R(−)-MDMA. The mean EF value for raw wastewater
collected during one week sampling was found to be 0.68 ± 0.04. This1.00
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Fig. 3. Enantiomeric fractions ofMDMA inwastewater samples fromUtrecht and Eindhoven
collected during a week in years 2010 and 2011, respectively.correlateswell with published data onmetabolism ofMDMA in humans
(Moore et al., 1996) and results from the UK study (Kasprzyk-Hordern
and Baker, 2012b), and suggests that MDMA found in the sewage of
Utrecht sampled in 2010 results from MDMA abuse rather than direct
disposal of unused drug.
In contrast, in the 2011 sampling campaign, MDMAwas found to be
racemic (EF = 0.51) during the ﬁrst 2 days of sampling, with a slow
increase of EF to 0.57 throughout the sampling week (cf. Fig. 3). It is im-
portant to mention that an increase in EF (showing enrichment with
R(−)-MDMA) correlated well with the decrease in daily loads of
MDMA, indicating higher contribution from consumed MDMA to the
overall mass loads throughout the sampling week. Levels of MDA
(human urinary metabolite of MDMA) detected in 2010 were equiva-
lent to those observed in 2011.We identiﬁed but could not quantify en-
antiomers of MDA in wastewater in both 2010 and 2011, which proves
that MDMA was disposed of in 2011. Furthermore, MDMA proﬁling in
wastewater samples collected from Eindhoven during the same 2011
sampling campaign revealed that average EF of MDMA in these samples
was, similarly to 2010 sampling, 0.69 ± 0.03 (Fig. 3).
3.2. Amphetamine in the city of Eindhoven
3.2.1. Loads of amphetamine in wastewater
The loads of amphetamine in the STP (in g/day) in both sampling
campaigns are shown in Fig. 4. The average load of amphetamine in
the sewage inﬂuent of Eindhoven was 1431 g/day in 2011, which is
14 times higher than the average load observed in 2010 (99 g/day).
These results raised suspicions about the origin of high amphetamine
loads. The average normalised load of amphetamine in the inﬂuent
from the city of Eindhoven in 2011 was 3040 mg/day/1000 inhabitants
(Thomas et al., 2012). This loadwould roughly correspond to an average
consumption of 4.7 kg of pure amphetamine per day, taking into
account an excretion factor of 3.3 (Zuccato et al., 2008). Assuming a
daily dose of 0.4 g of pure amphetamine this would be equivalent to a
prevalence of 1.5% for the people between 15 and 64 years living in
the catchment area of Eindhoven, which is 3 times higher than the
last reported ﬁgure of 0.4% in 2009 (European Monitoring Centre for
Drugs and Drug Addiction, Statistical Bulletin, 2012). The corresponding
prevalence calculated for the Sunday of 4% is even more unrealistic.
As in the case of MDMA, in order to verify whether the high mass
loads of amphetamine in the wastewater observed in 2011 result from
consumption or direct disposal of unused amphetamine, enantiomeric
proﬁling of wastewater was undertaken.
3.2.2. Enantiomeric proﬁling of amphetamine
Amphetamine, similarly to MDMA, is a chiral compound with one
asymmetric carbon. It can exist in the form of two enantiomers, which
signiﬁcantly differ in potency: S(+)-amphetamine has twice as high
stimulant activity than R(−)-amphetamine (Anderson et al., 1978).
Amphetamine is most commonly synthesised via the Leuckart method0
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Fig. 4. Daily mass loads of amphetamine in wastewater entering the STP of Eindhoven
calculated from samples collected during a week in years 2010 and 2011, respectively.
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selective method involves reduction of appropriate diastereoisomers of
norephedrine or norpseudoephedrine (King, 2009). Both S(+)- and
S(+)/R(−)-amphetamine are prescription medications. Amphetamine
can also be excreted as a result of metabolism of methamphetamine
and certain prescription drugs. For example, R(−)-amphetamine is
excreted as a result of administration of selegiline (marketed as R(−)-
enantiomer). S(+)-Amphetamine is formed as a result of an ad-
ministration of clobenzorex. On the other hand metabolism of
famprofazone leads to the formation of S(+)/R(−)-amphetamine.
Similarly, administration of fenproporex leads to the formation of
S(+)/R(−)-amphetamine. Benzphetamine metabolism results in
the formation of S(+)-amphetamine (Cody, 2002). Furthermore,
metabolism of amphetamine is known to be stereoselective: S(+)-
amphetamine metabolises faster than R(−)-enantiomer (Kasprzyk-
Hordern and Baker, 2012b).
Due to different legal and illicit uses of amphetamine available in
different enantiomeric forms, distinction between consumption and di-
rect disposal of unused amphetamine poses a signiﬁcant challenge
(Kasprzyk-Hordern and Baker, 2012b). In the present study amphet-
amine found inwastewaterwas racemic in both 2010 and 2011 sampling
campaigns (Fig. 5) (0.54 ± 0.02 and 0.53 ± 0.02 in Utrecht 2010 and
2011 respectively and 0.52 ± 0.01 and 0.52 ± 0.02 in Eindhoven 2010
and 2011 respectively). These results did not correlate with results
from another study undertaken by the authors in England, where am-
phetamine found in wastewater was enriched with R(−)-enantiomer
(median EF = 0.64) indicating abuse of racemic amphetamine
(Kasprzyk-Hordern and Baker, 2012b). Indeed, amphetamine is usually
abused as racemate.
Furthermore, according to CVZ statistics in The Netherlands,
only S(+)-amphetamine is prescribed (dexamfetamine 11 kg/2010)
(The Health Care Insurance Board, 2013). These are relatively low levels
when compared to illegal use (usage of amphetamine: 1.5–2 tonnes year-
ly) (European Commission Directorate General for Justice, 2013; survey-
based estimates of usage). Methamphetamine, which metabolises to1.00
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Fig. 5. Enantiomeric fractions of amphetamine in wastewater samples from Utrecht and
Eindhoven collected during a week in years 2010 and 2011, respectively.amphetamine, is not popular in TheNetherlands: usage ismainly restrict-
ed to small niches in the gay scene and amongst psychonauts due to
the limited availability and higher price € 100 per g (Nabben et al.,
2010). In 2010 (Bijlsma et al., 2012) and 2011 (Thomas et al., 2012) no
methamphetamine at levels above the LOD was detected in wastewater
from the cities of Utrecht and Eindhoven during the week long monitor-
ing campaigns. Therefore, amphetamine levels in Dutch wastewaters
formed as a result of metabolism of methamphetamine are negligible.
Amphetamine can also be excreted in different enantiomeric forms as a
result of metabolism of methamphetamine and certain prescription
drugs (e.g. selegiline, prescription in The Netherlands 2.3 kg in 2010
(The Health Care Insurance Board, 2013), which leads to the metabolic
formation of R(−)-amphetamine and R(−)-methamphetamine). Again,
these quantities are insigniﬁcant when compared to actual estimated
abuse of amphetamine in The Netherlands. Therefore, the amphetamine
case is not clear cut in TheNetherlandswhen compared to theUK. Further
work will have to be undertaken to fully understand sources of amphet-
amine in Dutch wastewaters. There are two obvious reasons, which
could be considered in order to explain the presence of racemic amphet-
amine in wastewater.
- Direct disposal of unused amphetamine (relatively high contribu-
tion from the disposal of unused amphetamine to the overall load
in wastewater).
- Illicit use of both racemic amphetamine and enantiomerically pure
S(+)-amphetamine.
4. Conclusions
A sampling campaign undertaken in 2010 and 2011 in two Dutch
cities: Utrecht and Eindhoven aiming at veriﬁcation of illicit drug
consumption revealed that the levels of MDMA found in 2011 in the
city of Utrecht did not correspond with those observed in the previous
year 2010. Enantiomeric proﬁling of wastewater samples collected in
Utrecht and Eindhoven in years 2010–11 proved that MDMA is usually
present in wastewater due to its consumption (MDMA enriched with
R(−)-enantiomer). Excessively high mass loads of MDMA during sam-
pling campaign in Utrecht in 2011were shown to be racemic indicating
direct disposal of unusedMDMA possibly as a result of a police raid at a
nearby illegal production facility. The fact that levels of MDA were sim-
ilar in 2010 and 2011 in wastewater from Utrecht also supports this
conclusion since the only aberrant level wasMDMA. Due to the removal
efﬁciency of only 5% for MDMA in the STP of Utrecht (Bijlsma et al.,
2012) this large quantity was directly disposed to the aquatic environ-
ment. Further researchneeds to beundertaken to investigate the impact
in the environment.
Enantiomeric proﬁling was also undertaken in order to verify the
origin of unexpectedly high mass loads of amphetamine in the city of
Eindhoven in the 2011 sampling campaign. Unfortunately, due to the
different legal and illicit uses of amphetamine available in different
enantiomeric forms, a distinction between consumption and direct
disposal of unused amphetamine in Dutch wastewater could not be
achieved. Further research will be undertaken to provide comprehen-
sive veriﬁcation of the sources of amphetamine in wastewater in The
Netherlands.
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